Shelhigh Signs Consent Order Suspending Distribution Of All Products
This article was originally published in The Gray Sheet
Executive Summary
Tissue product manufacturer Shelhigh signed a court order on June 22 agreeing to stop distributing its entire product line until the company brings its production process in line with FDA standards
You may also be interested in...
U.K. Regulatory Agency Prioritizes Safety Over International Standards Work
The U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) has turned its focus away from international standards work to concentrate instead on investigating medical device safety issues
U.K. Regulatory Agency Prioritizes Safety Over International Standards Work
The U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) has turned its focus away from international standards work to concentrate instead on investigating medical device safety issues
FDA Follows Up Shelhigh Seizure With Formal Request For Recall
FDA is leaning on tissue product manufacturer Shelhigh to recall its entire product line after all inventory at its manufacturing facility was seized by federal marshals last month